NVST vs XRAY: stock comparison and AI forecast
Envista Holdings Corp (NVST) and Dentsply Sirona Inc. (XRAY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
NVST Envista Holdings Corp
- Market Cap
- $4.01B
- P/E Ratio
- 7.0x
- Size
- mid-cap
- AI Forecast
XRAY Dentsply Sirona Inc.
- Price
- $10.09 -9.4% · 6M
- Market Cap
- $2.01B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- NVST is 2.0 times larger than XRAY by market capitalization ($4.01B against $2.01B).
- NVST turns 22.0% of its revenue into net income, against -3.4% for XRAY.
- XRAY carries 2.83 times debt per unit of equity, against 0.82 times for NVST.
- XRAY yields 6.36% in dividends; NVST pays none.
- Both companies share the SEC industry classification Dental Equipment & Supplies.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | NVST | XRAY |
|---|---|---|
| Market Cap | $4.01B | $2.01B |
| P/E Ratio | 6.99x | – |
| P/B Ratio | 1.30x | 1.48x |
| Dividend Yield | – | 6.36% |
| EPS | $3.57 | $-0.87 |
| Book Value/Share | $19.23 | $6.80 |
| Revenue/Share | $17.92 | $17.93 |
| FCF/Share | $1.51 | $0.52 |
Profitability & Margins
| Metric | NVST | XRAY |
|---|---|---|
| ROE | 20.5% | -8.9% |
| ROA | 11.3% | -2.3% |
| ROIC | 15.2% | -1.4% |
| Gross Margin | 55.9% | 50.5% |
| Operating Margin | 25.4% | -1.5% |
| Net Margin | 22.0% | -3.4% |
| EBT Margin | 23.8% | -2.5% |
| Tax Rate | 7.4% | -34.1% |
Financial Health
| Metric | NVST | XRAY |
|---|---|---|
| Current Ratio | 2.45x | 1.63x |
| Quick Ratio | 2.10x | 1.04x |
| D/E Ratio | 0.82x | 2.83x |
| Financial Leverage | 1.82x | 3.83x |
| Interest Coverage | 46.8x | 0.5x |
| Working Capital | $1.19B | $761M |
Cash Flow
| Metric | NVST | XRAY |
|---|---|---|
| Operating Cash Flow | $302M | $272M |
| Free Cash Flow | $242M | $103M |
| Capital Spending | -$60M | -$169M |
| OCF Growth YoY | 0.6% | 23.1% |
| FCF Growth YoY | -7.8% | 28.8% |
| FCF/Sales | 8.4% | 2.9% |
| CapEx/Sales | 2.1% | 4.7% |
Operational Efficiency
| Metric | NVST | XRAY |
|---|---|---|
| Asset Turnover | 0.51x | 0.69x |
| Receivables Turnover | 6.4x | – |
| Inventory Turnover | 4.5x | 2.5x |
| Fixed Assets Turnover | 9.6x | 4.2x |
| Days Sales Outstanding | 57 days | – |
| Days Inventory | 82 days | 146 days |
| Payables Period | – | 49 days |
Income Statement
| Metric | NVST | XRAY |
|---|---|---|
| Total Revenue | $2.88B | $3.58B |
| Operating Income | $731M | -$55M |
| Net Income | $634M | -$121M |
| R&D Expense | $122M | $171M |
| SG&A Expense | $1.18B | $1.46B |
| Cost of Goods Sold | $1.27B | $1.77B |
Dividend & Shareholder Information
| Metric | NVST | XRAY |
|---|---|---|
| Dividends Per Share | – | $0.64 |
| Shares Outstanding | 161M | 199M |
| Net Income Growth | 4041.2% | – |
NVST vs XRAY: stock comparison and AI forecast
Which is bigger, NVST or XRAY?
NVST is 2.0 times larger than XRAY by market capitalization ($4.01B against $2.01B).
Which one does Intratio's AI model rank higher, NVST or XRAY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.